Meghan Reilly

Meghan Reilly has over two decades of experience in the healthcare and medical sales sectors, currently serving as a Regional Sales Manager at Jazz Pharmaceuticals since April 2019. In this role, Meghan is responsible for the launch and promotion of the orphan drug Xywav for rare disease narcolepsy, targeting a diverse range of healthcare professionals. Notably, Meghan achieved the distinction of President's Club Winner in 2021, ranking #1 nationally, and was selected as the first Area Trainer for Oxybate. Previous roles include Client Development Manager at Natus Neurology, Neurodiagnostics & Sleep Supervisor at Florida Hospital, and various leadership positions at Precision Health Concepts. Meghan holds a Bachelor of Science degree in Social Sciences from Florida State University.